Carazolol
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 57775-29-8 |
| ATCvet code | QC07AA90 |
| PubChem | CID 71739 |
| IUPHAR ligand | 569 |
| ChemSpider | 64783 |
| UNII | 29PW75S82A  |
| Chemical data | |
| Formula | C18H22N2O2 |
| Mol. mass | 298.38 |
| SMILES | eMolecules & PubChem |
Carazolol is a high affinity antagonist/partial inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.[1]
[edit] References
- ^ Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi:10.1016/0024-3205(79)90102-4. PMID 41147.
[edit] External links
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
